ENTA - Enanta Pharmaceuticals Inc

Name: Enanta Pharmaceuticals Inc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Jay R. Luly	871.9K	$9.04M	-
Other	Yat Sun Or	374.9K	$3.89M	-
Other	Brendan Luu	41.6K	$431.7K	-
Other	Tara Lynn Kieffer	33.9K	$351.8K	-
Other	Scott T. Rottinghaus	23.8K	$246.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 6, 2024	Jay R. Luly71	President and CEO	Sell10b5-1	5,142	$8.06	$41,444.52	-0.6%	-10.3%	+82.5%
Dec 6, 2024	Paul J Mellett63	Chief Fin. & Admin Officer	Sell10b5-1	2,591	$8.06	$20,883.46	-2.7%	-10.3%	+82.5%
Dec 6, 2024	Yat Sun Or59	Chief Scientific Officer	Sell10b5-1	2,591	$8.06	$20,883.46	-0.7%	-10.3%	+82.5%
Dec 6, 2024	Scott T. Rottinghaus69	Chief Medical Officer	Sell10b5-1	866	$8.06	$6,979.96	-4.6%	-10.3%	+82.5%
Dec 6, 2024	Brendan Luu	Chief Business Officer	Sell10b5-1	2,283	$8.06	$18,400.98	-6.0%	-10.3%	+82.5%
Dec 6, 2024	Tara Lynn Kieffer54	Chief Product Strategy Officer	Sell10b5-1	2,283	$8.06	$18,400.98	-7.2%	-10.3%	+82.5%
Jul 15, 2024	Scott T. Rottinghaus69	Chief Medical Officer	Sale+OE10b5-1	11,945	$15.97	$190,746.77	-35.5%	-31.6%	-60.2%
Jun 17, 2024	Tara Lynn Kieffer54	Chief Product Strategy Officer	Sell10b5-1	7,266	$12.33	$89,589.78	-18.3%	-2.2%	-41.6%
Dec 13, 2023	Terry Vance	Director	Sell	15,295	$9.12	$139,490.40	-72.5%	+49.9%	-35.2%
Dec 5, 2023	Jay R. Luly71	President and CEO	Sell	7,230	$9.63	$69,624.90	-0.9%	+65.3%	-9.9%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC